Literature DB >> 12856793

Economic impact of a hepatitis A epidemic in a mid-sized urban community: the case of Spokane, Washington.

Lynne Bownds1, Rebecca Lindekugel, Paul Stepak.   

Abstract

Data reported here represent an effort to build on previous work regarding the costs of hepatitis A. We expand this work to include an estimation of the costs of hepatitis A on a community wide basis. In addition to calculating the costs of disease management and health care delivery, we include an analysis of additional child care costs, lost productivity, costs associated with outbreak management, and the impact on affected restaurants that required public notification and the administration of Immune Globulin to patrons. The work reported here is specific to Spokane county, Washington. The objective is to enable the Spokane Regional Health District to communicate to the community costs of managing an outbreak of hepatitis A and to inform implementation of a hepatitis A vaccination program on a community wide basis. The average cost (direct and indirect) per case for the entire sample is 2,683 dollars. The estimated total cost for the sample (145 cases) is approximately 370,193 dollars. Inpatient hospital care is the largest direct medical expense and lost productivity is a major indirect cost to the community. Lessons learned from undertaking this task include: (1) costs incurred are not immediately obvious, (2) without infrastructure in place, tracking costs is difficult, if not impossible, (3) potential for large expenditures is apparent, (4) estimates are consistent with those generated in previous studies, and (5) previous findings of vaccination of certain high-risk populations as a cost-efficient approach is corroborated.

Entities:  

Mesh:

Year:  2003        PMID: 12856793     DOI: 10.1023/a:1023981924010

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  8 in total

1.  The cost of hepatitis A infections in American adolescents and adults in 1997.

Authors:  J J Berge; D P Drennan; R J Jacobs; A Jakins; A S Meyerhoff; W Stubblefield; M Weinberg
Journal:  Hepatology       Date:  2000-02       Impact factor: 17.425

2.  Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-05-02

3.  Cost effectiveness of vaccinating food service workers against hepatitis A infection.

Authors:  R J Jacobs; S F Grover; A S Meyerhoff; T A Paivana
Journal:  J Food Prot       Date:  2000-06       Impact factor: 2.077

4.  The cost of a food-borne outbreak of hepatitis A in Denver, Colo.

Authors:  C B Dalton; A Haddix; R E Hoffman; E E Mast
Journal:  Arch Intern Med       Date:  1996-05-13

5.  Cost-effectiveness analysis of hepatitis A vaccination strategies for adults.

Authors:  J B O'Connor; T F Imperiale; M E Singer
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

6.  The cost-effectiveness of adolescent hepatitis A vaccination in states with the highest disease rates.

Authors:  R J Jacobs; H S Margolis; P J Coleman
Journal:  Arch Pediatr Adolesc Med       Date:  2000-08

7.  Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Authors: 
Journal:  MMWR Recomm Rep       Date:  1996-12-27

8.  Continuing outbreak of hepatitis A linked with intravenous drug abuse in Multnomah County.

Authors:  C P Schade; D Komorwska
Journal:  Public Health Rep       Date:  1988 Sep-Oct       Impact factor: 2.792

  8 in total
  6 in total

Review 1.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Risk factors for hospitalisation and associated costs among patients with hepatitis A associated with imported pomegranate arils, United States, 2013.

Authors:  E E Epson; A Cronquist; K Lamba; A C Kimura; R Hassan; D Selvage; C S McNeil; A K Varan; J L Silvaggio; L Fan; X Tong; P R Spradling
Journal:  Public Health       Date:  2016-05-04       Impact factor: 2.427

Review 3.  Costing infectious disease outbreaks for economic evaluation: a review for hepatitis A.

Authors:  Jeroen Luyten; Philippe Beutels
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

4.  Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children.

Authors:  Abigail Hankin-Wei; David B Rein; Alfonso Hernandez-Romieu; Mallory J Kennedy; Lisa Bulkow; Eli Rosenberg; Monica Trigg; Noele P Nelson
Journal:  Vaccine       Date:  2016-06-27       Impact factor: 3.641

5.  Hepatitis A: A Case Report Example of a Growing Epidemiological Threat.

Authors:  Adam Foster; Stephanie Hernandez
Journal:  Spartan Med Res J       Date:  2019-03-04

6.  A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks.

Authors:  Janetta E Skarp; Laura E Downey; Julius W E Ohrnberger; Lucia Cilloni; Alexandra B Hogan; Abagael L Sykes; Susannah S Wang; Hiral Anil Shah; Mimi Xiao; Katharina Hauck
Journal:  Appl Health Econ Health Policy       Date:  2021-06-11       Impact factor: 3.686

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.